Loading
institutionsInstitution
UMC Utrecht Cancer Center
The Dutch university cancer centre that invented the MR-linac and sits at the heart of the Utrecht organoid and Oncode ecosystem.
Also called: University Medical Center UtrechtUtrecht Cancer Center
Overview
UMC Utrecht's radiotherapy department under Jan Lagendijk and Bas Raaymakers conceived and built the first integrated MRI-guided linear accelerator, commercialised by Elekta as Unity and used to treat the first patients in Utrecht in 2017. The Cancer Center works with the neighbouring Hubrecht Institute, where Hans Clevers's group grew the first adult stem cell-derived organoids, and with the Princess Máxima Center for paediatric oncology on the same campus; Utrecht is also the seat of the Dutch Oncode Institute. Clinical strengths include image-guided and adaptive radiotherapy, head and neck and gastrointestinal oncology, haematology and a phase 1 unit, and the centre holds OECI accreditation. Patients access MR-guided radiotherapy trials, organoid-guided drug testing studies and molecular tumour boards.
Location
Utrecht, NL
Type
cancer center · Utrecht University
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#146 · 34 points (0 Newsweek + 0 NCI + 34 from 17 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to University Medical Center Utrecht, including child institutions. 1,422 works · 20,323 citations · 87% open access · 12% clinical trials · 3% reviews.
Oncology works per year
3172022
2932023
3212024
3042025
1872026
Most works
- Marc G. Besselink177 works
- Bas Groot Koerkamp142 works
- Hjalmar C. van Santvoort109 works
- Lois A. Daamen86 works
- Ignace H. J. T. de Hingh86 works
- Olivier R. Busch83 works
- Karijn P.M. Suijkerbuijk83 works
- Martijn W.J. Stommel81 works
- Miriam Koopman69 works
- Bert A. Bonsing62 works
Most cited
- MR-linac and adaptive radiotherapy
- Organoid research (with Hubrecht Institute)
- Head and neck oncology
- Haematology
- Oncode Institute
Bas W. Raaymakers
Professor of Experimental Clinical Physics, UMC Utrecht
MR-guided radiotherapyMR-linac developmentMedical physics
Physicist who invented the MR-linac, letting radiotherapy see and adapt to the tumour in real time.
Jürgen Kuball
Daily Board member, Strategic Program Cancer
HaematologyCellular immunotherapyStem cell transplantation
Utrecht haematologist and immunotherapy researcher on the daily board of UMC Utrecht's cancer programme, known for gamma-delta T cell receptor-engineered cell therapies.
Wouter de Laat
Chair, Strategic Program Cancer
Genome organisationChromatin biologyCancer genomics
Genome biologist who chairs UMC Utrecht's Strategic Program Cancer, the umbrella for more than 800 cancer researchers in Utrecht.
Similar pages
- InstitutionAtrium Health Wake Forest Baptist Comprehensive Cancer Center
Shares Functional (ex vivo) drug testing, Patient-derived organoids, Lab models that fail to predict what happens in patients, SBRT / SABR (stereotactic radiotherapy).
- IdeaGrow tumour organoids together with the patient's own immune cells
Shares Netherlands Cancer Institute (NKI-AvL), Functional (ex vivo) drug testing, Patient-derived organoids, Lab models that fail to predict what happens in patients.
- IdeaCoverage-with-evidence registries for MR-guided and adaptive radiotherapy
Shares Elekta, MR-guided adaptive radiotherapy, SBRT / SABR (stereotactic radiotherapy), IMRT / IGRT (modern external beam).
- IdeaZebrafish avatars for a drug answer within a week
Shares Functional (ex vivo) drug testing, Lab models that fail to predict what happens in patients, Pancreatic ductal adenocarcinoma, Colorectal cancer.
- IdeaAutomated combination discovery: patient-sample screens feeding Bayesian platform trials
Shares Functional (ex vivo) drug testing, Patient-derived organoids, Lab models that fail to predict what happens in patients, Colorectal cancer.
- TechnologyOrganoid-guided therapy at scale
Shares Sato 2009: single Lgr5 stem cells build crypt-villus organoids, Functional (ex vivo) drug testing, Patient-derived organoids.
- IdeaRadiotherapy for everyone who needs it by 2040
Shares Elekta, SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam).
- IdeaGrow each trial patient's tumour as organoids to decide which platform arm opens next
Shares Functional (ex vivo) drug testing, Patient-derived organoids, Lab models that fail to predict what happens in patients, Pancreatic ductal adenocarcinoma.
cancers
fronts
technologies
companies
institutions
people
bottlenecks
key papers
Open-source projects
All open source in oncology →Open-source projects that this organisation maintains, from OnCo's own catalogue: licence and last activity as the repository reported them on the day of the fetch. Listing is not endorsement; check the licence before reuse and the validation before clinical use.
A Bioconductor package for characterising mutational patterns and signatures in base substitutions, indels and structural variants.
Classifies central nervous system tumours within the operation from sparse nanopore methylation data, so the surgeon can adapt the resection.